Clinical Trial Update: Plasma Rich in Growth Factors (PRGF) for the Treatment of Lichen Sclerosus Atrophicus of the Vulva [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Plasma Rich in Growth Factors (PRGF) for vulvar lichen sclerosus has been withdrawn. No trial results or primary outcomes were report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lichen Sclerosus

Drugs mentioned

• Plasma Rich in Growth Factors (PRGF)

Snippet

Sponsor: Fundación Eduardo Anitua | Conditions: Lichen Sclerosus of Vulva | Phase 3 | Status: WITHDRAWN